BeatO, the Delhi based health-tech startup, today announced the closure of its Pre-Series A round of ₹ 11.75 Crores (~US $1.714 million). Orios Venture Partners led the funding round with participation from existing investors -Blume Ventures, Leo Capital and Vishal Sampat.
BeatO focuses on meeting the end to end needs of a person with diabetes. As is commonly known, a diabetes management program requires regular exercise, controlled diet, medicines and diagnostics and regular monitoring of blood sugar.
BeatO helps a diabetic self-manage these activities by providing a full stack of services and products on a web and app ecosystem. The consumer starts to use BeatO by purchasing their smartphone -based glucometer that connects with the mobile app.
The BeatO Glucometer connects to the user’s smartphone and works with the feature-rich BeatO app. The product and its concept are superior to normal glucometers in the market.
